Farabursen

DB18127InvestigationalGene Therapies

RGLS-8429 is an investigational anti-miR-17 oligonucleotide.

Mechanism
Curator reviewed
Code names
CYX082 · RGLS-8429

Resolves to

Compound
UNIIJ7AP97D44Q

What you can answer from here — as of April 27, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which companies are running trials of Farabursen, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In